Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers for the first through third quarters, according to a new report. Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the […]
Investors spent less money on fewer deals in the medical device sector during the third quarter and so far this year, bucking the overall growth trend for venture capital-backed firms, according to a new report. Venture capital investment fell -19.7% to $772.7 million during the three months ended Sept. 30, with deal volume down -20.3% […]
Venture Capital funding in the healthcare sector during the third quarter of 2017 stayed mostly in line with the previous quarter while digital health deals saw a significant drop, according to a PricewaterhouseCoopers and CB Insights MoneyTree report. VC funding during the third quarter of 2017 was directly in line with the previous quarter, but […]
Venture capital funding during the 2nd quarter was down from Q1, according to a PricewaterhouseCoopers and CB Insights MoneyTree report released last week. Funding in the life sciences industry was down from the 1st quarter at 147 deals grossing $2.6 billion, lower than Q1’s 182 deals at $3.7 billion. The medical device industry saw a […]
The investors behind a venture capital fund added accounting firm PricewaterhouseCoopers to a lawsuit alleging that the fund’s founder, biotech notable Stephen Burrill, and other fund executives looted it for $17 million. The Burrill Life Sciences Capital Fund III 1st sued last July, accusing Burrill, longtime outside-counsel-turned-staff-counsel Victor Hebert and CFO Helena Sen of diverting the cash […]
January 20, 2015 by Brad Perriello
November 17, 2014 by Brad Perriello
Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.
Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.